Literature DB >> 15286394

Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.

Kevin G Fuller1, Julie K Olson, Laurence M Howard, J Ludovic Croxford, Stephen D Miller.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) and Theiler's murine encephalitis virus-induced demyelinating disease (TMEV-IDD) are two clinically relevant murine models of multiple sclerosis (MS). Like MS, both are characterized by mononuclear cell infiltrate into the central nervous system and demyelination. EAE is induced by either the administration of protein or peptide in adjuvant or by the adoptive transfer of encephalitogenic T-cell blasts into naïve recipients. The relative merits of each of these protocols are compared. Depending on the type of question asked, different mouse strains and peptides are used. Different disease courses are observed with different strains and different peptides in active EAE. These variations are addressed, and grading of mice in EAE is discussed. In addition to EAE induction, useful references for other disease indicators, such as delayed-type hypersensitivity, in vitro proliferation, and immunohistochemistry, are provided. TMEV-IDD is a useful model for understanding the potential viral etiology of MS. This chapter provides detailed information on the preparation of viral stocks and subsequent intracerebral infection of mice. In addition, virus plaque assay and disease assessment are discussed. Recombinant TMEV strains have been created for the study of molecular mimicry; these strains incorporate 30 various amino acid myelin epitopes within the leader region of TMEV.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15286394     DOI: 10.1385/1-59259-805-6:339

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  10 in total

1.  Mesenchymal stem cells: Molecular characteristics and clinical applications.

Authors:  Farbod Rastegar; Deana Shenaq; Jiayi Huang; Wenli Zhang; Bing-Qiang Zhang; Bai-Cheng He; Liang Chen; Guo-Wei Zuo; Qing Luo; Qiong Shi; Eric R Wagner; Enyi Huang; Yanhong Gao; Jian-Li Gao; Stephanie H Kim; Jian-Zhong Zhou; Yang Bi; Yuxi Su; Gaohui Zhu; Jinyong Luo; Xiaoji Luo; Jiaqiang Qin; Russell R Reid; Hue H Luu; Rex C Haydon; Zhong-Liang Deng; Tong-Chuan He
Journal:  World J Stem Cells       Date:  2010-08-26       Impact factor: 5.326

2.  Pattern of CXCR7 Gene Expression in Mouse Brain Under Normal and Inflammatory Conditions.

Authors:  Ghazal Banisadr; Joseph R Podojil; Stephen D Miller; Richard J Miller
Journal:  J Neuroimmune Pharmacol       Date:  2015-05-22       Impact factor: 4.147

3.  Cleavage of transaldolase by granzyme B causes the loss of enzymatic activity with retention of antigenicity for multiple sclerosis patients.

Authors:  Brian Niland; Gabriella Miklossy; Katalin Banki; William E Biddison; Livia Casciola-Rosen; Antony Rosen; Denis Martinvalet; Judy Lieberman; Andras Perl
Journal:  J Immunol       Date:  2010-03-01       Impact factor: 5.422

4.  Mechanisms and pharmacology of neuropathic pain in multiple sclerosis.

Authors:  T Iannitti; B J Kerr; B K Taylor
Journal:  Curr Top Behav Neurosci       Date:  2014

5.  Integrin/Chemokine receptor interactions in the pathogenesis of experimental autoimmune encephalomyelitis.

Authors:  Ghazal Banisadr; Samantha R Schwartz; Joseph R Podojil; Linda A Piccinini; Stefan Lanker; Stephen D Miller; Richard J Miller
Journal:  J Neuroimmune Pharmacol       Date:  2014-01-30       Impact factor: 4.147

6.  Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis.

Authors:  Michael Basler; Sarah Mundt; Tony Muchamuel; Carlo Moll; Jing Jiang; Marcus Groettrup; Christopher J Kirk
Journal:  EMBO Mol Med       Date:  2014-01-16       Impact factor: 12.137

7.  Genetic deletion of Mst1 alters T cell function and protects against autoimmunity.

Authors:  Konstantin V Salojin; Brian D Hamman; Wei Chun Chang; Kanchan G Jhaver; Amin Al-Shami; Jeannette Crisostomo; Carrie Wilkins; Ann Marie Digeorge-Foushee; Jason Allen; Nita Patel; Suma Gopinathan; Julia Zhou; Amr Nouraldeen; Theodore C Jessop; Jeffrey T Bagdanoff; David J Augeri; Robert Read; Peter Vogel; Jonathan Swaffield; Alan Wilson; Kenneth A Platt; Kenneth G Carson; Alan Main; Brian P Zambrowicz; Tamas Oravecz
Journal:  PLoS One       Date:  2014-05-22       Impact factor: 3.240

8.  Analysis of nociception, sex and peripheral nerve innervation in the TMEV animal model of multiple sclerosis.

Authors:  Jessica L Lynch; Nathan J Gallus; Marna E Ericson; Alvin J Beitz
Journal:  Pain       Date:  2007-09-04       Impact factor: 7.926

9.  Hematopoietic cell activation in the subventricular zone after Theiler's virus infection.

Authors:  Gwendolyn E Goings; Adriana Greisman; Rachel E James; Leanne Kf Abram; Wendy Smith Begolka; Stephen D Miller; Francis G Szele
Journal:  J Neuroinflammation       Date:  2008-10-15       Impact factor: 8.322

10.  TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease.

Authors:  Bhanu P Pappu; Anna Borodovsky; Timothy S Zheng; Xuexian Yang; Ping Wu; Xingwen Dong; Shawn Weng; Beth Browning; Martin L Scott; Li Ma; Lihe Su; Qiang Tian; Pascal Schneider; Richard A Flavell; Chen Dong; Linda C Burkly
Journal:  J Exp Med       Date:  2008-04-14       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.